The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Intravital Microscopy in Human Solid Tumors
Official Title: Intravital Microscopy (IVM) in Human Solid Tumors
Study ID: NCT03823144
Brief Summary: This study will investigate the tumor-associated vasculature of patients with solid tumors. The investigators will use a technology known as intravital microscopy (IVM) in order to visualize in real-time the vessels associated with solid tumors. The IVM observations may determine if an individual patient's tumor vessels would be amenable to receiving systemic therapy, based on the functionality of the vessels.
Detailed Description: PRIMARY OBJECTIVE: To determine the feasibility and clinical utility of performing HIVM in patients with solid tumors during standard course of treatment (surgical resection). SECONDARY OBJECTIVES: 1. Compare the microscopic observation of the tumor-associated vessels with normal tissue (e.g. peritoneal surface or normal brain tissue) in each individual subject. 2. Correlate the microscopic observations of the tumor-associated vessels with pathologic grade of tumor. 3. To correlate the microscopic observation of the microvasculature with tumor-specific and overall survival. OUTLINE: Patients receive fluorescein intravenously (IV) and undergo HIVM over 1-2 minutes per field. After completion of study, patients are followed up at 2-3 weeks after surgery.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Mayo Clinic Florida, Jacksonville, Florida, United States
Name: Emmanuel M Gabriel, M.D., Ph.D.
Affiliation: Mayo Clinic
Role: PRINCIPAL_INVESTIGATOR